HEADLINES

-=6

Indian Market
Indian equity markets up by 0.27% Nifty up by 16.25 pts and settle at 6009.50 Sensex up by 50.54 pts at 19764.78 Bank Nifty down by 8.65 pts at 12778.20

DAILY EQUITY NEWSLETTER

4TH JANUARY 2013

Global Market
European markets were up with FTSE down by 9.43 closed at 6017,CAC down by 20.18 closed at 3713 and DAX down by 25.01 closed at 7753. Dow future was down 20.00 closed at 13311.00

HEADLINES
Offtake target bigger challenge than production: Coal India Govt may consider ordinance for Hindustan Zinc stake sale IGL keen to buy ADB stake in Petronet LNG Dr Reddy's Laboratories launches hair loss tablets in US

WWW.EPICRESEARCH.CO

09752199966

 MARKET ANALYSIS:
The 50-unit S&P CNX Nifty moved past the psychological 6,000 level as key benchmark indices eked out small gains. The barometer index, BSE Sensex, was provisionally up 38.66 points or 0.2%, up 59.61 points from the day's low and off 33.40 points from the day's high. The market breadth, indicating the overall health of the market, was positive. Index heavyweight Reliance Industries (RIL) extended intraday gains in late trade. The BSE Sensex was up 38.66 points or 0.2% to 19,752.90. The S&P CNX Nifty was up 12.15 points or 0.2% to 6,005.40. Among the 30-share Sensex pack, 17 declined while the rest of them gained. IT pivotals rose after US lawmakers early this week reached a last-minute deal to avert the fiscal cliff. US is the biggest outsourcing market for the Indian IT firmsIT major Tata Consultancy Services rose 1.5%.India's third largest software services exporter by revenues Wipro gained 0.83%.Shares of banking giant State Bank of India (SBI) gained 0.88% to Rs 2,469.75 after striking a 52-week high of Rs 2,482.20 in intraday today, 3 January 2013. Dr Reddy's Laboratories advanced 2.35% after the company said it has launched Finasteride Tablets 1 mg in the US market.

FIIs and DIIs

CATEGORY DATE BUY SELL NET

STOCKS TO WATCH CROMPTON ADANI BHEL PFC

FII DII

3-Jan-13 3-Jan-13

3089.48 996.46

1692.11 1902.42

1397.37 -905.96

NIFTY DAILY PIVOTS

PIVOT NIFTY R4 6097 R3 6066 R2 6035 R1 6022 PP 6004 S1 5991 S2 5973 S3 5942 S4 5911

SCRIPS IN BAN PERIOD

SUZLON

WWW.EPICRESEARCH.CO

09752199966

GAINERS AND LOOSERS

EXPERT OPINION
NIFTY

DAILY NIFTY GAINERS

SCRIPS RATE VOL. (000) PR. CLOSE NET CHAN GE % CHANG E

Nifty looks Consolidate Strategy: Buy on dips Support: 5970 Resistance: 6060
BANK NIFTY

Dr Reddys Lab Cairn India Bharti Airtel ONGC DLF

1882.30

584.79

1837.70

44.60

2.43

327.50 328.00 279.80 238.90

2442.67 3677.59 4215.38 5511.61

320.00 321.05 274.60 235.20

7.50 6.95 5.20 3.70

2.34 2.16

Bank Nifty looks Consolidate Strategy: Buy on dips Support: 12700 Resistance: 12840 .0

1.89 1.57

PREVIOUS PERFORMANCE
TYPE SCRIP B/S RESULT

DAILY NIFTY LOOSERS CASH

SCRIPS RATE VOL. (000) PR. CLOSE NET CHAN GE % CHAN GE

AMTEK ZEE ENTERTAINMENT ADANI ENTERPRISE HCL TECHNOLOGIES

S B B S

CASH FUTURE

NOT EXECUTED TGT ACHEIVED NOT EXECUTED NOT EXECUTED

Tata Power Lupin PNB Sun Pharma Inds. Hero MotoCorp

110.15 608.85 896.80 733.85 1887.95

1607.01 475.31 587.50 520.44 334.61

112.00 614.90 905.50 740.90 1905.35

-1.85 -6.05 -8.70 -7.05 -17.40

-1.65 FUTURE -0.98 -0.96 -0.95 -0.91

09752199966

MARKET CALLS
CASH
SCRIPS BHARTI AIRTEL ICICI BANK ACTION BUY SELL LEVEL 328.90 1168.00 1ST TARGET 330.90 1158.00 2ND TARGET 333.90 1145.00 STOP LOSS 326.90 1178.00

FUTURE
SCRIPS . ALLAHBAD BANK ADANI ENETERPRISES BUY 181.30 182.30 183.80 180.30 ACTION LEVEL 1
ST

TARGET

ND

TARGET

STOP LOSS

SELL

282.00

281.00

279.50

283.00

Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.